Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
36
A.Huczyński,M.Antoszczak
[28]FuchsD.,HeinoldA.,OpelzG.,DanielV.,NaujokatC.(2009)Salinomycininduces
apoptosisandovercomesapoptosisresistanceinhumancancercells,Biochem.Bio-
phys.Res.Commun.390,743–749.
[29]RiccioniR.,DupuisM.L.,BernabeiM.,PetrucciE.,PasquiniL.,MarianiG.,
CianfrigliaM.,TestaU.(2010)Thecancerstemcellselectiveinhibitorsalinomycinis
ap-glycoproteininhibitor,BloodCellsMol.Dis.45,86–92.
[30]FuchsD.,DanielV.,SadeghiM.,OpelzG.,NaujokatC.(2010)Salinomycinovercomes
ABCtransporter-mediatedmultidrugandapoptosisresistanceinhumanleukemia
stemcell-likeKG-1acells,Biochem.Biophys.Res.Commun.394,1098–1104.
[31]LepperE.R.,NooterK.,VerweijJ.,AcharyaM.R.,FiggW.D.,SparreboomA.(2005)
Mechanismsofresistancetoanticancerdrugs:theroleofthepolymorphicABCtrans-
portersABCB1andABCG2,Pharmacogenomics6,115–138.
[32]TiwariA.K.,SodaniK.,DaiC.L.,AshbyC.R.,ChenZ.S.(2011)RevistingtheABCsof
multidrugresistanceincancerchemotherapy,Curr.Pharm.Biotechnol.12,570–594.
[33]LeeC.H.(2010)ReversingagentsforATP-bindingcassettedrugtransporters,Meth-
odsMol.Biol.596,325–340.
[34]LuD.,ChoiM.Y.,YuJ.,CastroJ.E.,KippsT.J.,CarsonD.A.(2011)Salinomycin
inhibitsWntsignalingandselectivelyinducesapoptosisinchroniclymphocyticleu-
kemiacells,Proc.Natl.Acad.Sci.USA108,13253–13257.
[35]ReyaT.,CleversH.(2005)Wntsignalinginstemcellsandcancer,Nature434,843–850.
[36]WangY.(2011)Effectsofsalinomycinoncancerstemcellinhumanlungadenocarci-
nomaA549cells,Med.Chem.7,106–111.
[37]DongT.T.,ZhouH.M.,WangL.L.,FengB.,LvB.,ZhengM.H.(2011)Salinomycin
selectivelytargets‘CD133+’cellsubpopulationsanddecreasesmalignanttraitsincol-
orectalcancerlines,Ann.Surg.Oncol.18,1797–1804.
[38]KetolaK.,HilvoM.,HyötyläinenT.,VuoristoA.,RuskeepäA.L.,OrešičM.,Kal-
lioniemiO.,IljinK.(2012)Salinomycininhibitsprostatecancergrowthandmigration
viainductionofoxidativestress,K.Br.J.Cancer106,99–106.
[39]KimK.Y.,YuS.N.,LeeS.Y.,ChunS.S.,ChoiY.L.,ParkY.M.,SongC.S.,ChatterjeeB.,
AhnS.C.(2011)Salinomycin-inducedapoptosisofhumanprostatecancercellsdueto
accumulatedreactiveoxygenspeciesandmitochondrialmembranedepolarization,
Biochem.Biophys.Res.Commun.413,80–86.
[40]IljinK.,KetolaK.,VainioP.,HalonenP.,KohonenP.,FeyV.,GrafströmR.C.,PeräläM.,
KallioniemiO.(2009)High-throughputcell-basedscreeningof4910knowndrugsand
drug-likesmallmoleculesidentifiesdisulfiramasaninhibitorofprostatecancercell
growth,Clin.CancerRes.15,6070–6078.
[41]KimW.K.,KimJ.H.,YoonK.,KimS.,RoJ.,KangH.S.,YoonS.(2012)Salinomycin,
ap-glycoproteininhibitor,sensitizesradiation-treatedcancercellsbyincreasingDNA
damageandinducingG2arrest,Invest.NewDrugs30,1311–1318.
[42]ParkS.H.,WangX.,LiuR.,LamK.S.,WeissR.H.(2008)Highthroughputscreening
ofasmallmoleculeone-bead-one-compoundcombinatoriallibrarytoidentifyattenua-
torsofp21aschemotherapysensitizers,CancerBiol.Ther.7,2015–2022.
[43]IdogawaM.,SasakiY.,SuzukiH.,MitaH.,ImaiK.,ShinomuraY.,TokinoT.(2009)
Asinglerecombinantadenowirusexpressingp53andp21-targetingartificialmi-
croRNAsefficientlyinducesapoptosisinhumancancercells,Clin.CancerRes.15,
3725–3732.
[44]KimJ.H.,ChaeM.J.,KimW.K.,KimY.J.,KangH.S.,KimH.S.,YoonS.(2011)Sali-
nomycinsensitizescancercellstotheeffectsofdoxorubicinandetoposidetreatment
byincreasingDNAdamageandreducingp21protein,Br.J.Pharmacol.162,773–784.
